Design, synthesis, biological evaluation and molecular dynamics studies of 4-thiazolinone derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitors

References

• Balmith, M., & Soliman, M. E. (2017). Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus. Molecular Biosystems, 13(3), 585–597. doi:10.1039/C6MB00803H
   PubMedGoogle Scholar
• Bohm, H. J. (1992). The computer program LUDI: A new method for the de novo design of enzyme inhibitors. Journal of Computer-Aided Molecular Design, 6(1), 61–78.
   PubMed Web of Science ®Google Scholar
• Byon, J. C., Kusari, A. B., & Kusari, J. (1998). Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Molecular and Cellular Biochemistry, 182(1/2), 101–108.
   PubMed Web of Science ®Google Scholar
• Chen, J., Wang, X., Pang, L., Zhang, J. Z. H., & Zhu, T. (2019). Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations. Nucleic Acids Research, 47(13), 6618–6631. doi:10.1093/nar/gkz499
   PubMed Web of Science ®Google Scholar
• Chen, X., Gan, Q., Feng, C., Liu, X., & Zhang, Q. (2019). Investigation of selective binding of inhibitors to PTP1B and TCPTP by accelerated molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 37(14), 3697–3706. doi:10.1080/07391102.2018.1526117
   PubMed Web of Science ®Google Scholar
• Chen, Y.-Y., Chu, H.-M., Pan, K.-T., Teng, C.-H., Wang, D.-L., Wang, A. H.-J., … Meng, T.-C. (2008). Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. Journal of Biological Chemistry, 283(50), 35265–35272. doi:10.1074/jbc.M805287200
   PubMed Web of Science ®Google Scholar
• Cheng, A., & Merz, K. M. Jr. (2003). Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. Journal of Medicinal Chemistry, 46(17), 3572–3580. doi:10.1021/jm020266b
   PubMed Web of Science ®Google Scholar
• Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., … Tremblay, M. L. (2002). Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Developmental Cell, 2(4), 497–503. doi:10.1016/S1534-5807(02)00149-1
   PubMed Web of Science ®Google Scholar
• Douty, B., Wayland, B., Ala, P. J., Bower, M. J., Pruitt, J., Bostrom, L., … Yue, E. W. (2008). Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorganic & Medicinal Chemistry Letters, 18(1), 66–71. doi:10.1016/j.bmcl.2007.11.012
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Walters, W. P., & Murcko, M. A. (2002). Guiding molecules towards drug-likeness. Current Opinion in Drug Discovery & Development, 5(4), 540–549.
   PubMedGoogle Scholar
• Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., … Kennedy, B. P. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 283(5407), 1544–1548. doi:10.1126/science.283.5407.1544
   PubMed Web of Science ®Google Scholar
• Eldehna, W. M., Abdelrahman, M. A., Nocentini, A., Bua, S., Al-Rashood, S. T., Hassan, G. S., … Supuran, C. T. (2019). Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity. Bioorganic Chemistry, 90, 103102. doi:10.1016/j.bioorg.2019.103102
   PubMed Web of Science ®Google Scholar
• Fakhar, Z., Govender, T., Maguire, G. E. M., Lamichhane, G., Walker, R. C., Kruger, H. G., & Honarparvar, B. (2017). Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics. Molecular Biosystems, 13(6), 1223–1234. doi:10.1039/C7MB00110J
   PubMedGoogle Scholar
• Fernandez-Silva, M. J., Alonso-Gonzalez, A., Gonzalez-Perez, E., Gestal-Otero, J. J., & Diaz-Gravalos, G. J. (2019). Health literacy in patients with type 2 diabetes: A cross-sectional study using the HLS-EU-Q47 questionnaire. Semergen, 45(1), 30–36. doi:10.1016/j.semerg.2018.08.003
   PubMedGoogle Scholar
• Goldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000). Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. Journal of Biological Chemistry, 275(6), 4283–4289. doi:10.1074/jbc.275.6.4283
   PubMed Web of Science ®Google Scholar
• Grant, B. J., Rodrigues, A. P., ElSawy, K. M., McCammon, J. A., & Caves, L. S. (2006). Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics, 22(21), 2695–2696. doi:10.1093/bioinformatics/btl461
   PubMed Web of Science ®Google Scholar
• Hess, B. (2008). P-LINCS: A parallel linear constraint solver for molecular simulation. Journal of Chemical Theory and Computation, 4(1), 116–122. doi:10.1021/ct700200b
   PubMed Web of Science ®Google Scholar
• Jiang, C. S., Ge, Y. X., Cheng, Z. Q., Wang, Y. Y., Tao, H. R., Zhu, K., & Zhang, H. (2019). Discovery of new selective butyrylcholinesterase (BChE) inhibitors with anti-abeta aggregation activity: Structure-Based virtual screening, hit optimization and biological evaluation. Molecules, 24(14), 2568. doi:10.3390/molecules2414
   Web of Science ®Google Scholar
• Jin, W. Y., Ma, Y., Li, W. Y., Li, H. L., & Wang, R. L. (2018). Scaffold-based novel SHP2 allosteric inhibitors design using receptor-ligand pharmacophore model, virtual screening and molecular dynamics. Computational Biology and Chemistry, 73, 179–188. doi:10.1016/j.compbiolchem.2018.02.004
   PubMed Web of Science ®Google Scholar
• Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., … Kahn, B. B. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and Cellular Biology, 20(15), 5479–5489. doi:10.1128/MCB.20.15.5479-5489.2000
   PubMed Web of Science ®Google Scholar
• Li, X., Wang, X., Tian, Z., Zhao, H., Liang, D., Li, W., … Lu, S. (2014). Structural basis of valmerins as dual inhibitors of GSK3beta/CDK5. Journal of Molecular Modeling, 20(9), 2407. doi:10.1007/s00894-014-2407-1
   PubMed Web of Science ®Google Scholar
• Liu, G. (2004). Technology evaluation: ISIS-113715, Isis. Current Opinion in Molecular Therapeutics, 6(3), 331–336.
   PubMedGoogle Scholar
• Liu, J., Wang, F., Ma, Z., Wang, X., & Wang, Y. (2011). Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods. International Journal of Molecular Sciences, 12(2), 946–970. doi:10.3390/ijms12020946
   PubMed Web of Science ®Google Scholar
• Liu, W. S., Wang, R. R., Li, W. Y., Rong, M., Liu, C. L., Ma, Y., & Wang, R. L. (2019). Investigating the reason for loss-of-function of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) caused by Y279C mutation through molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2019.1634641
   Web of Science ®Google Scholar
• Liu, W. S., Wang, R. R., Sun, Y. Z., Li, W. Y., Li, H. L., Liu, C. L., … Wang, R. L. (2019). Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation. Journal of Cellular Biochemistry, 120(10), 17015–17029. doi:10.1002/jcb.28963
   PubMed Web of Science ®Google Scholar
• Loeffler, H. H., & Winn, M. D. (2013). Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain. Proteins: Structure, Function, and Bioinformatics, 81(11), 1931–1943. doi:10.1002/prot.24339
   PubMed Web of Science ®Google Scholar
• Ma, Y., Wang, S. Q., Xu, W. R., Wang, R. L., & Chou, K. C. (2012). Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach. PLoS One, 7(6), e38546. doi:10.1371/journal.pone.0038546
   PubMed Web of Science ®Google Scholar
• Machaba, K. E., Mhlongo, N. N., & Soliman, M. E. S. (2018). Induced mutation proves a potential target for TB therapy: A molecular dynamics study on LprG. Cell Biochemistry and Biophysics, 76(3), 345–356. doi:10.1007/s12013-018-0852-7
   PubMed Web of Science ®Google Scholar
• Maisuradze, G. G., Liwo, A., & Scheraga, H. A. (2009). Principal component analysis for protein folding dynamics. Journal of Molecular Biology, 385(1), 312–329. doi:10.1016/j.jmb.2008.10.018
   PubMed Web of Science ®Google Scholar
• Miyake, M., Koga, T., Kondo, S., Yoda, N., Emoto, C., Mukai, T., & Toguchi, H. (2017). Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans. European Journal of Pharmaceutical Sciences, 96, 373–380. doi:10.1016/j.ejps.2016.10.006
   PubMed Web of Science ®Google Scholar
• Ndagi, U., Mhlongo, N. N., & Soliman, M. E. (2017). The impact of Thr91 mutation on c-Src resistance to UM-164: Molecular dynamics study revealed a new opportunity for drug design. Molecular Biosystems, 13(6), 1157–1171. doi:10.1039/C6MB00848H
   PubMed Web of Science ®Google Scholar
• Ndagi, U., Mhlongo, N. N., & Soliman, M. E. (2018). Emergence of a promising lead compound in the treatment of triple negative breast cancer: An insight into conformational features and ligand binding landscape of c-Src protein with UM-164. Applied Biochemistry and Biotechnology, 185(3), 655–675. doi:10.1007/s12010-017-2677-z
   PubMed Web of Science ®Google Scholar
• Neves, B. J., Braga, R. C., Melo-Filho, C. C., Moreira-Filho, J. T., Muratov, E. N., & Andrade, C. H. (2018). QSAR-based virtual screening: Advances and applications in drug discovery. Front Pharmacol, 9, 1275. doi:10.3389/fphar.2018.01275
   PubMed Web of Science ®Google Scholar
• Olde Scheper, T. V., Meredith, R. M., Mansvelder, H. D., van Pelt, J., & van Ooyen, A. (2017). Dynamic Hebbian cross-correlation learning resolves the spike timing dependent plasticity conundrum. Front Comput Neurosci, 11, 119. doi:10.3389/fncom.2017.00119
   PubMed Web of Science ®Google Scholar
• Pol-Fachin, L., Fernandes, C. L., & Verli, H. (2009). GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations. Carbohydrate Research, 344(4), 491–500. doi:10.1016/j.carres.2008.12.025
   PubMed Web of Science ®Google Scholar
• Schneider, G., & Fechner, U. (2005). Computer-based de novo design of drug-like molecules. Nature Reviews Drug Discovery, 4(8), 649–663. doi:10.1038/nrd1799
   PubMed Web of Science ®Google Scholar
• Su, J., Liu, X., Zhang, S., Yan, F., Zhang, Q., & Chen, J. (2018). A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36(5), 1212–1224. doi:10.1080/07391102.2017.1317666
   PubMed Web of Science ®Google Scholar
• Sun, W., Zhang, B., Zheng, H., Zhuang, C., Li, X., Lu, X., … Xiu, Z. (2017). Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes. Life Sciences, 169, 52–64. doi:10.1016/j.lfs.2016.11.012
   PubMed Web of Science ®Google Scholar
• Sun, W., Zhuang, C., Li, X., Zhang, B., Lu, X., Zheng, Z., & Dong, Y. (2017). Varic acid analogues from fungus as PTP1B inhibitors: Biological evaluation and structure-activity relationships. Bioorganic & Medicinal Chemistry Letters, 27(15), 3382–3385. doi:10.1016/j.bmcl.2017.06.001
   PubMed Web of Science ®Google Scholar
• Susnow, R. G., & Dixon, S. L. (2003). Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition. Journal of Chemical Information and Computer Sciences, 43(4), 1308–1315. doi:10.1021/ci030283p
   PubMedGoogle Scholar
• Tadic, M., & Cuspidi, C. (2015). Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Archives of Cardiovascular Diseases, 108(4), 269–276. doi:10.1016/j.acvd.2015.01.009
   PubMed Web of Science ®Google Scholar
• Tang, J., Qu, Z., Luo, J., He, L., Wang, P., Zhang, P., … Huang, Y. (2018). Molecular dynamics simulations of the oil-detachment from the hydroxylated silica surface: Effects of surfactants, electrostatic interactions, and water flows on the water molecular channel formation. The Journal of Physical Chemistry B, 122(6), 1905–1918. doi:10.1021/acs.jpcb.7b09716
   PubMed Web of Science ®Google Scholar
• Thiyagarajan, V., Lin, S. H., Chang, Y. C., & Weng, C. F. (2016). Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking. Biomedicine & Pharmacotherapy, 80, 52–62. doi:10.1016/j.biopha.2016.02.020
   PubMed Web of Science ®Google Scholar
• Wan, H., Hu, J. P., Tian, X. H., & Chang, S. (2013). Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d. Physical Chemistry Chemical Physics, 15(4), 1241–1251. doi:10.1039/C2CP41388D
   PubMed Web of Science ®Google Scholar
• Wang, M.-Y., Jin, Y.-Y., Wei, H.-Y., Zhang, L.-S., Sun, S.-X., Chen, X.-B., … Wang, R.-L. (2015). Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors. European Journal of Medicinal Chemistry, 103, 91–104. doi:10.1016/j.ejmech.2015.08.037
   PubMed Web of Science ®Google Scholar
• Wesson, L., & Eisenberg, D. (1992). Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Science, 1(2), 227–235. doi:10.1002/pro.5560010204
   PubMed Web of Science ®Google Scholar
• Xu, L., Kong, R., Zhu, J., Sun, H., & Chang, S. (2016). Unraveling the conformational determinants of LARP7 and 7SK small nuclear RNA by theoretical approaches. Molecular Biosystems, 12(8), 2613–2621. doi:10.1039/C6MB00252H
   PubMedGoogle Scholar
• Yan, F., Liu, X., Zhang, S., Su, J., Zhang, Q., & Chen, J. (2019). Electrostatic interaction-mediated conformational changes of adipocyte fatty acid binding protein probed by molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 37(14), 3583–3595. doi:10.1080/07391102.2018.1520648
   PubMed Web of Science ®Google Scholar
• Yesudhas, D., Anwar, M. A., Panneerselvam, S., Durai, P., Shah, M., & Choi, S. (2016). Structural mechanism behind distinct efficiency of Oct4/Sox2 proteins in differentially spaced DNA complexes. PLoS One, 11(1), e0147240. doi:10.1371/journal.pone.0147240
   PubMed Web of Science ®Google Scholar
• Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., … Neel, B. G. (2002). PTP1B regulates leptin signal transduction in vivo. Developmental Cell, 2(4), 489–495. doi:10.1016/S1534-5807(02)00148-X
   PubMed Web of Science ®Google Scholar
• Zhai, M., Liu, S., Gao, M., Wang, L., Sun, J., Du, J., … Zhang, W. (2019). 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation. European Journal of Medicinal Chemistry, 168, 426–435. doi:10.1016/j.ejmech.2018.12.053
   PubMed Web of Science ®Google Scholar
• Zhang, J., Luan, C. H., Chou, K. C., & Johnson, G. V. (2002). Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling. Proteins: Structure, Function, and Genetics, 48(3), 447–453. doi:10.1002/prot.10173
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Zhang, N., Chen, W., Zhao, L., & Zhong, R. (2016). Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2alpha/CK2beta: Comparative molecular dynamics simulation studies. Physical Chemistry Chemical Physics, 18(13), 9202–9210. doi:10.1039/C5CP06276D
   PubMed Web of Science ®Google Scholar